Kore Potash features a diverse register of shareholders encompassing strategic corporate partners, institutional asset management firms, high-net-worth private investors, and public retail traders. Major institutional blocks are frequently held by specialized resource funds and key corporate stakeholders who back the development of its large-scale potash assets located within the Republic of Congo, alongside public market participants trading on alternative exchanges.
Precision BioSciences generates annual revenue that fluctuates based on milestone payments, upfront licensing fees, and collaborative research agreements with major pharmaceutical partners. Recent fiscal reports place its trailing annual revenues within the range of several million to over ten million dollars, varying significantly year-over-year depending on the timing and execution milestones achieved across its various drug development partnerships.